Bösche, Leif I <br/><br/>
Initial Experience With Novel Oral Anticoagulants During the First 45 Days After Left Atrial Appendage Closure With the Watchman Device.  [electronic resource] 

 -  Clinical cardiology  Dec 2015 
 - 720-4 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1932-8737 
<br/><br/><label>Standard No.: </label>10.1002/clc.22478  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Aged<br/>Aged, 80 and over<br/>Anticoagulants--adverse effects<br/>Atrial Appendage--drug effects<br/>Cardiac Surgical Procedures--adverse effects<br/>Dabigatran--adverse effects<br/>Echocardiography, Transesophageal<br/>Feasibility Studies<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Middle Aged<br/>Pilot Projects<br/>Retrospective Studies<br/>Rivaroxaban--adverse effects<br/>Stroke--etiology<br/>Survival Rate<br/>Thrombosis--etiology<br/>Treatment Outcome